SLC1A1 and schizophrenia: Besides confirming the neuroprotective role of EAAT3, some of the studies involving EAAT3-null mice report phenotypes consistent with an effect on GABAergic signaling, which has been strongly linked to some of the core features of schizophrenia [8].